No significant association of aspirin use with cerebral microbleeds in the asymptomatic elderly

Chi Kyung Kim, Hyuk Tae Kwon, Hyung Min Kwon

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background and purpose: Cerebral microbleeds (CMBs) may predict future risk for intracerebral hemorrhage (ICH). ICH is one of the most important complications of aspirin use. The association between aspirin use and CMBs is still controversial. In this context, we sought to investigate whether aspirin use is associated with CMBs in subjects without previous history of stroke. Methods: Asymptomatic elderly subjects (n = 1452; age ≥ 65 years) who visited for routine health check-ups were included in this study. CMBs were evaluated through T2*-weighted gradient-recalled echo MRI. Information about aspirin or warfarin use was obtained using a structured questionnaire. Results: A total of 138 subjects (9.5%) were found to have CMBs. In the group of aspirin use, 43 subjects (11.2%) had CMBs; among them 9 (2.3%) had strictly lobar microbleeds and 34 (8.9%) had deep or infratentorial microbleeds. Compared with the non-use group, the risk for CMBs did not increase in the group of aspirin use (adjusted odds ratio, 1.10; 95% confidence interval, 0.73-1.66). For the group of aspirin use above 5 years, the proportion of CMBs (11.1%) did not increase compared with the group of short-term use (≤ 5 years, 9.5%, p = 0.99) and non-use group (8.9%, p = 0.66). Conclusions: We found that the prevalence of CMBs did not increase in the group of aspirin use, and the presence of CMBs was not associated with the duration of aspirin use in asymptomatic elderly subjects without a history of stroke or transient ischemic attack.

Original languageEnglish
Pages (from-to)56-58
Number of pages3
JournalJournal of the Neurological Sciences
Volume319
Issue number1-2
DOIs
Publication statusPublished - 2012 Aug 15
Externally publishedYes

Fingerprint

Aspirin
Cerebral Hemorrhage
Stroke
Transient Ischemic Attack
Warfarin
Odds Ratio
Confidence Intervals
Health

Keywords

  • Antiplatelet
  • Aspirin
  • Cerebral microbleeds
  • Hemorrhagic stroke
  • Intracerebral hemorrhage

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

No significant association of aspirin use with cerebral microbleeds in the asymptomatic elderly. / Kim, Chi Kyung; Kwon, Hyuk Tae; Kwon, Hyung Min.

In: Journal of the Neurological Sciences, Vol. 319, No. 1-2, 15.08.2012, p. 56-58.

Research output: Contribution to journalArticle

@article{7b2a1fd8548d49b99c401bb8d0e33231,
title = "No significant association of aspirin use with cerebral microbleeds in the asymptomatic elderly",
abstract = "Background and purpose: Cerebral microbleeds (CMBs) may predict future risk for intracerebral hemorrhage (ICH). ICH is one of the most important complications of aspirin use. The association between aspirin use and CMBs is still controversial. In this context, we sought to investigate whether aspirin use is associated with CMBs in subjects without previous history of stroke. Methods: Asymptomatic elderly subjects (n = 1452; age ≥ 65 years) who visited for routine health check-ups were included in this study. CMBs were evaluated through T2*-weighted gradient-recalled echo MRI. Information about aspirin or warfarin use was obtained using a structured questionnaire. Results: A total of 138 subjects (9.5{\%}) were found to have CMBs. In the group of aspirin use, 43 subjects (11.2{\%}) had CMBs; among them 9 (2.3{\%}) had strictly lobar microbleeds and 34 (8.9{\%}) had deep or infratentorial microbleeds. Compared with the non-use group, the risk for CMBs did not increase in the group of aspirin use (adjusted odds ratio, 1.10; 95{\%} confidence interval, 0.73-1.66). For the group of aspirin use above 5 years, the proportion of CMBs (11.1{\%}) did not increase compared with the group of short-term use (≤ 5 years, 9.5{\%}, p = 0.99) and non-use group (8.9{\%}, p = 0.66). Conclusions: We found that the prevalence of CMBs did not increase in the group of aspirin use, and the presence of CMBs was not associated with the duration of aspirin use in asymptomatic elderly subjects without a history of stroke or transient ischemic attack.",
keywords = "Antiplatelet, Aspirin, Cerebral microbleeds, Hemorrhagic stroke, Intracerebral hemorrhage",
author = "Kim, {Chi Kyung} and Kwon, {Hyuk Tae} and Kwon, {Hyung Min}",
year = "2012",
month = "8",
day = "15",
doi = "10.1016/j.jns.2012.05.017",
language = "English",
volume = "319",
pages = "56--58",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - No significant association of aspirin use with cerebral microbleeds in the asymptomatic elderly

AU - Kim, Chi Kyung

AU - Kwon, Hyuk Tae

AU - Kwon, Hyung Min

PY - 2012/8/15

Y1 - 2012/8/15

N2 - Background and purpose: Cerebral microbleeds (CMBs) may predict future risk for intracerebral hemorrhage (ICH). ICH is one of the most important complications of aspirin use. The association between aspirin use and CMBs is still controversial. In this context, we sought to investigate whether aspirin use is associated with CMBs in subjects without previous history of stroke. Methods: Asymptomatic elderly subjects (n = 1452; age ≥ 65 years) who visited for routine health check-ups were included in this study. CMBs were evaluated through T2*-weighted gradient-recalled echo MRI. Information about aspirin or warfarin use was obtained using a structured questionnaire. Results: A total of 138 subjects (9.5%) were found to have CMBs. In the group of aspirin use, 43 subjects (11.2%) had CMBs; among them 9 (2.3%) had strictly lobar microbleeds and 34 (8.9%) had deep or infratentorial microbleeds. Compared with the non-use group, the risk for CMBs did not increase in the group of aspirin use (adjusted odds ratio, 1.10; 95% confidence interval, 0.73-1.66). For the group of aspirin use above 5 years, the proportion of CMBs (11.1%) did not increase compared with the group of short-term use (≤ 5 years, 9.5%, p = 0.99) and non-use group (8.9%, p = 0.66). Conclusions: We found that the prevalence of CMBs did not increase in the group of aspirin use, and the presence of CMBs was not associated with the duration of aspirin use in asymptomatic elderly subjects without a history of stroke or transient ischemic attack.

AB - Background and purpose: Cerebral microbleeds (CMBs) may predict future risk for intracerebral hemorrhage (ICH). ICH is one of the most important complications of aspirin use. The association between aspirin use and CMBs is still controversial. In this context, we sought to investigate whether aspirin use is associated with CMBs in subjects without previous history of stroke. Methods: Asymptomatic elderly subjects (n = 1452; age ≥ 65 years) who visited for routine health check-ups were included in this study. CMBs were evaluated through T2*-weighted gradient-recalled echo MRI. Information about aspirin or warfarin use was obtained using a structured questionnaire. Results: A total of 138 subjects (9.5%) were found to have CMBs. In the group of aspirin use, 43 subjects (11.2%) had CMBs; among them 9 (2.3%) had strictly lobar microbleeds and 34 (8.9%) had deep or infratentorial microbleeds. Compared with the non-use group, the risk for CMBs did not increase in the group of aspirin use (adjusted odds ratio, 1.10; 95% confidence interval, 0.73-1.66). For the group of aspirin use above 5 years, the proportion of CMBs (11.1%) did not increase compared with the group of short-term use (≤ 5 years, 9.5%, p = 0.99) and non-use group (8.9%, p = 0.66). Conclusions: We found that the prevalence of CMBs did not increase in the group of aspirin use, and the presence of CMBs was not associated with the duration of aspirin use in asymptomatic elderly subjects without a history of stroke or transient ischemic attack.

KW - Antiplatelet

KW - Aspirin

KW - Cerebral microbleeds

KW - Hemorrhagic stroke

KW - Intracerebral hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=84862757760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862757760&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2012.05.017

DO - 10.1016/j.jns.2012.05.017

M3 - Article

VL - 319

SP - 56

EP - 58

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -